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Abstract
Poisonings—from lamp oil ingestion continue to occur worldwide among the pediatric 
population despite preventive measures such as restricted sale of colored and scented lamp oils. 
This suggests that optimal prevention practices for unintentional pediatric exposures to lamp oil 
have yet to be identified and/or properly implemented.
Objective—To characterize demographic, health data, and potential risk factors associated with 
reported exposures to lamp oil by callers to poison centers (PCs) in the US and discuss their public 
health implications.
Study design—. This was a two part study in which the first part included characterizing all 
exposures to a lamp oil product reported to the National Poison Data System (NPDS) with regard 
to demographics, exposure, health, and outcome data from 1/1/2000 to 12/31/2010. Regional 
penetrance was calculated using NPDS data by grouping states into four regions and dividing the 
number of exposure calls by pediatric population per region (from the 2000 US census). Temporal 
analyses were performed on NPDS data by comparing number of exposures by season and around 
the July 4th holiday. Poisson regression was used to model the count of exposures for these 
analyses. In the second part of this project, in order to identify risk factors we conducted a 
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telephone-based survey to the parents of children from five PCs in five different states. The 10 
most recent lamp oil product exposure calls for each poison center were systematically selected 
for inclusion. Calls in which a parent or guardian witnessed a pediatric lamp oil product ingestion 
were eligible for inclusion. Data on demographics, exposure information, behavioral traits, and 
health were collected. A descriptive analysis was performed and Fisher’s exact test was used to 
evaluate associations between variables. All analyses were conducted using SAS v9.3.
Results—Among NPDS data, 2 years was the most common patient age reported and states in 
the Midwestern region had the highest numbers of exposure calls compared to other regions. 
Exposure calls differed by season (p<0.0001) and were higher around the July 4th holiday 
compared to the rest of the days in July (2.09 vs. 1.89 calls/day, p<0.002). Most exposures 
occurred inside a house, were managed on-site and also had a “no effect” medical outcome. Of the 
50 PC-administered surveys to parents or guardians, 39 (78%) met inclusion criteria for analysis. 
The majority of ingestions occurred in children that were 2 years of age, that were not alone, 
involved tiki torch fuel products located on a table or shelf, and occurred inside the home. The 
amount of lamp oil ingested did not appear to be associated with either the smell (p = 0.19) or the 
color of the oil (p = 1.00) in this small sample. Approximately half were asymptomatic (n = 18; 
46%), and of those that reported symptoms, cough was the most common (n = 20, 95%) 
complaint.
Conclusions—Lamp oil product exposures are most common among young children (around 2 
years of age) while at home, not alone and likely as a result of the product being in a child-
accessible location. Increasing parental awareness about potential health risks to children from 
these products and teaching safe storage and handling practices may help prevent both exposures 
and associated illness. These activities may be of greater benefit in Midwestern states and during 
summer months (including the period around the July 4th holiday).
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Introduction
Lamp oil is made of paraffin, a low-viscosity hydrocarbon that is poorly absorbed from the 
gastrointestinal tract after ingestion. The primary health risk from lamp oil ingestion is from 
unintentional aspiration due to lamp oil’s low viscosity.1 Significant pulmonary injury 
including chemical pneumonitis, respiratory distress, and death is possible following 
aspiration.2–4 Related products such as tiki torch fuel (a predominantly petroleum-based 
product) and other hydrocarbons can produce similar health effects as lamp oil. Since 2001, 
an estimated 18,000 exposures to lamp oil products were reported to poison centers (PCs). 
Of these, four resulted in fatality among children 5 years of age and younger.5 According to 
data collected by PCs from 2001 to 2009 and uploaded to the national PC reporting database 
known as the National Poison Data System (NPDS), the majority of lamp oil exposure calls 
concerned children 5 years of age or younger (n = 17,967; 84%).5 The true pediatric 
morbidity and mortality rates associated with lamp oil and associated products, such as 
citronella and tiki torch fuels, in the United States (US) are unknown.
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Several factors have been theorized to contribute to unintentional pediatric lamp oil 
exposures. These include inadequate adult supervision, improper storage techniques such as 
storing in unlabeled easy-to-open containers placed within the child ’ s reach, and physical 
properties such as a colored liquid appearing like juice or an odor resembling a pleasant 
fragrance.4,6–7 A United States study noted an increased frequency of pediatric lamp oil 
exposure calls during certain Jewish holidays when the use of oil-based lamps is more 
frequent than during non-holidays.8 European countries have been attempting to reduce the 
morbidity and mortality from lamp oil ingestions in young children for years with mixed 
results.9–11 The optimal exposure prevention techniques likely have yet to be identified 
and/or properly implemented.9 Our objectives were to characterize demographic, exposure, 
health, and outcome data associated with lamp oil product exposures reported to PCs in the 
US and discuss their public health implications.
Methods
Characterization of NPDS lamp oil product exposures
NPDS is a national database and data management system owned by the American 
Association of Poison Control Centers (AAPCC). It receives information on calls made by 
the public to the 57 PCs across the US in near, real-time. We used a cross-sectional study to 
identify all pediatric lamp oil product exposures reported to PCs from 1/1/2000 to 
12/31/2010 by reviewing NPDS data. PC and NPDS data use a system of codes and 
standardized outcome categories (Table 1) to track potentially hazardous exposures. We 
defined a lamp oil product exposure as any reported exposure with the AAPCC generic code 
for lamp oil exposures (201031). Aggregate data on daily exposure call count, age, gender, 
state where exposure occurred, date of exposure, site of exposure, medical outcome, 
management site, clinical effects, and therapies were collected and analyzed using Microsoft 
(MS) Excel 2010 and SAS 9.3. PC records/notes were not available for review. PC 
penetrance describes the rate of exposures called to PCs of the implicated substance per year 
per unit population. This measure was used to compare regions of the country and determine 
which areas have higher reported exposures given a standard population. For the regional 
penetrance analyses, states were first grouped into four major regions according to the US 
census (Fig. 1): Northeast (Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, 
Connecticut, New York, Pennsylvania, and New Jersey); Midwest (Wisconsin, Michigan, 
Illinois, Indiana, Ohio, Missouri, North Dakota, South Dakota, Nebraska, Kansas, 
Minnesota, and Iowa), South (Delaware, Maryland, District of Columbia, Virginia, West 
Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, 
Mississippi, Alabama, Oklahoma, Texas, Arkansas, and Louisiana) and West (Idaho, 
Montana, Wyoming, Nevada, Utah, Colorado, Arizona, New Mexico, Alaska, Washington, 
Oregon, California, and Hawaii). We then compared lamp oil product exposure call volume 
among regions. Next, region-specific PC penetrance was determined by dividing the total 
number of region-specific lamp oil product exposures by the corresponding region’s total 
estimated pediatric population (<5 years of age) from 2000 to 2010, multiplied by 10,000.12 
A chi-square analysis was conducted to investigate the association between penetrance and 
region. Seasons were defined as: Winter (December, January, and February), Spring (March, 
April, and May), Summer (June, July, and August), and Fall (September, October, and 
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November). The number of lamp oil product exposure calls occurring in each season from 
2000 to 2010 was then determined. Poisson regression was used to model the count of 
exposures per day by season. The number of exposures occurring the day before, on, and 
after Independence Day (July 4th) from 2000 to 2010 was compared to the count during the 
remaining days in July also using Poisson regression. All analyses were conducted using 
SAS v9.3.
Multi-center study of risk factors for lamp oil product ingestions
The PCs of Utah, Wisconsin, New Jersey, Kentucky, and Cincinnati, Ohio each obtained 
approval from their Institutional Review Board (IRB) to participate in telephone survey 
component of the study. A lamp oil product was defined as a product that is used as fuel for 
lamp oil-based lamps, which was verified by reviewing the call narrative. The PC-based co-
investigators used the following codes to identify potential lamp oil product ingestions: lamp 
oil (0201031), other types of hydrocarbons (0039510), and miscellaneous essential oils 
(0077360). PC staff then selected the 10 most recent calls from the study period of 1/1/2007 
to 12/31/2008. Each PC enrolled callers beginning with the latest call, until 10 eligible calls 
had been consented for participation. The same questionnaire was administered by all the 
PCs and is available upon request. Inclusion criteria for study enrollment included: (1) age 
≤5 years; (2) an exposure to lamp oil or associated product (e.g, tiki torch fuel); and (3) an 
exposure route of ingestion (including aspiration). De-identified results were provided to 
CDC co-investigators for analysis. Data were analyzed using SAS v9.3.
Results
Characterization of NPDS lamp oil product exposures
From 2000 to 2010, 23,536 pediatric exposure calls about lamp oil products were reported to 
NPDS. A mean of six exposure calls per day was reported across all PCs (range: 1–19). The 
mean age of exposed children was 2 years, median 20 months, and range 13 days to 5 years. 
Most reported exposures involved males (n = 13,758; 59%). Table 2 illustrates the frequency 
distributions for exposure site, management site, medical outcome, clinical effects, (e.g., 
signs, symptoms, laboratory abnormalities, etc.) and therapies used according to standard 
NPDS classifications.13 The most common site of exposure was the patient’s home (n = 
21,510; 91%) and most did not require medical treatment in a health-care facility (n = 
14,506; 62%). Most had either no or minimal clinical symptoms (nausea, vomiting, etc.) as a 
result of the exposure (n = 19,739; 84%). The proportion of pediatric lamp oil product 
exposure calls reporting death as the outcome in NPDS data for the study period was 0.03% 
(7 deaths) and the proportion that developed symptoms was 45%. The most common 
reported adverse health effect was cough/choke (n = 8,027; 34%). The most common 
therapy given was dilute/irrigate/wash (n = 15,179; 64.5%). The number of lamp oil product 
exposures reported to NPDS differed significantly by region (p value < 0.0001). The 
Midwest had observed exposure frequencies that were 20.5% higher than expected on the 
basis of the null hypothesis of no association between region and exposures and the 
Northeast had observed frequencies that were 22.6% lower than expected. Observed 
frequencies in the South and West were 0.58% and 2.2% lower than expected, respectively. 
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The Midwest had the highest penetrance of all the regions (1.08 exposures per 10,000 
population). The Northeast had the lowest of the regions (0.69 exposures per 10,000).
The mean count of reported lamp oil product exposures per day by season from 2000 to 
2010 was as follows: Fall, 6.0; Summer, 6.4; Spring, 5.7; and Winter, 5.6. When comparing 
the daily seasonal mean values, there was a statistically significant difference (p < 0.001) for 
every comparison except between Spring and Winter (p = 0.30). The number of reported 
lamp oil product exposures around July 4th was significantly higher (2.09 vs 1.89 calls/day, 
p < 0.002) compared to the number of exposures for the rest of the month of July.
Multi-center study of risk factors for lamp oil product ingestions
Ten telephone surveys were completed from each PC for a total of 50 surveys. However, 11 
surveys for ingestional exposures to air fresheners, herbal medications, perfumes, stove 
fuels, lubricants, and furniture grease were excluded from the analysis. Demographic 
information is summarized in Table 3. The median age was 2 years. Most patients were male 
(n = 22; 56%). Exposure information and circumstances surrounding ingestion can be found 
in Table 4. When asked about place of ingestion, more than half of the respondents reported 
the ingestions occurred in the child’s house (n = 22; 56%). The remainder of ingestions took 
place on a deck/patio/porch (23%), backyard (15%), public place (2%), or garage (2%). The 
majority of the children were not alone at the time of ingestion (n = 30; 77%) and reportedly 
drank less than a mouthful (n = 24; 62%). Most ingestions occurred in the afternoon 
(defined as between 12:00 and 17:59; n = 15, 38%) and evening (defined as between 18:00 
and 23:59; n = 15, 38%).
The majority of callers reported that the ingested product was not stored close (within 1–3 
feet) to food (n = 35; 90%). None of the 39 children could read at the time the ingestion 
occurred and only one was able to recognize warning symbols. Most of the children drank 
the lamp oil product from the original container (n = 23; 59%) and most of the original 
containers did not have a child-resistant closure (n = 14; 61%). For the 16 in which the 
exposure was associated with a non-original container, the lamp oil or related product was 
stored in either a lamp, candle, or tiki torch.
Among all lamp oil products, tiki torch fuel was the most commonly ingested product type 
(n = 13; 33%). A table or counter was the most commonly reported storage location (n = 6; 
15%). When asked about lamp oil color, 18 (46%) reported a presence of a color and out of 
these, yellow or gold was the most common color reported (n = 12; 67%). Only 9 (23%) 
described the products’ smell as pleasant. The majority of children (n = 24; 62%) ingested 
less than a mouthful, and 3 (8%) ingested more than a mouthful. Of these three, none 
described the product’s smell as pleasant. The amount of lamp oil ingested did not appear to 
be associated with either the smell of the oil (p = 0.19) or the presence of color (p = 1.00) in 
this small sample. One child had a previous history of pica and approximately one-third of 
the children had a previous history of eating non-food items (n = 15; 38%). Eleven (28%) 
callers reported previous contact with their PC or their doctor because their child had eaten a 
non-food item on a previous occasion. None of the children who had previously reported 
non-food item ingestions were able to recognize warning or hazard symbols. Approximately 
half (n = 5; 45%) of these children had a non-food eating habit as reported by the 
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respondent. Approximately half of the children who ingested a lamp oil product had no 
symptoms after ingestion (n = 18; 46%). The maximum number of symptoms reported was 
six. All of the children who reported symptoms after exposure developed at least one 
symptom within 4 h. In two of these instances, however, the initial symptoms reported were 
choking and/or vomiting with more serious symptoms (cough and fever) occurring 5–12 h 
after the ingestion. The local PC was the agency/healthcare provider most often notified first 
after an ingestion (n = 33; 85%). Of those that initially called an agency/healthcare provider 
(n = 36), approximately half reported no symptoms (n = 17; 44%). Among all children, 12 
(31%) sought care at a healthcare facility (HCF) defined as a hospital emergency department 
(ED), pediatrician’s office, or urgent care center. Two children sought care though they were 
asymptomatic. Most of the children who did not seek care drank less than a mouthful (n = 
19; 49%). Of those who sought care, half drank a mouthful or more (n = 6; 50%) and most 
eventually went to the local ED (n = 9; 75%).
Of the 12 children who sought care at a HCF, ten (83%) received treatment or diagnostic 
studies and therapies described in Table 5. The average length of stay in the ED reported by 
survey respondents was 3.1 h (range: 0–8 h; mode: 2 h). Of these ten, three (30%) were 
eventually admitted. The mean length of admission reported was 1.7 days (range: 1–2 days). 
Thirty three of those surveyed provided answers regarding current health status of the 
affected child. Two (6%) had a history of asthma. Five (15%) had a previous history of 
breathing problems. One (3%) reported chronic breathing problems after lamp oil exposure 
and one (3%) reported development of a persistent cough that had resolved by the time of 
this survey. Three (10%) children were placed on medication(s) by a physician as a result of 
lamp oil or related product-related illness after the acute event. These medications included 
albuterol inhaler, steroid inhaler, dexamethasone, and antibiotics. It is unknown whether 
these medications were given in the inpatient or outpatient settings. At the time of the 
survey, none of the children required continued treatment with any of these medications.
Discussion
Ingestions of lamp oil in children continue to occur according to calls reported to PCs. These 
findings suggest that public health education activities such as increasing parental awareness 
about safe handling and storage practices along with the health risks from these products are 
needed. Because it appears that the Midwest may have somewhat higher exposure 
frequencies, this region may be a good place to start such activities. The reasons for the 
increased prevalence of potential lamp oil exposures in this region are unclear. It is possible 
that these regions may have communities that use more of these types of products such as 
particular cultural and religious groups like the Amish14 Perhaps the reasons for why the 
Northeast region has fewer exposures than expected are because the population may be less 
likely to call their PCs after an exposure to lamp oil or related products, may purchase fewer 
of these products, and/or that their regional poisoning prevention and public health 
campaigns are more effective. Devices using lamp oil or related products (e.g., tiki torch 
fuels) are more commonly used during the warmer months of summer, which likely explains 
the higher prevalence of exposure calls during summer months. We did find a statistically 
significantly increase in exposure calls nationally around 4th of July, likely reflecting an 
increased use of the product during this time period in the United States. This finding 
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associated with the national holiday of July 4th likely reflects cultural practices specific to 
the US and may not be generalizable to other countries. Given the mobility and inherent 
exploratory nature of 2 year olds, it is not surprising that this age group had the highest 
number of reported exposures and actual ingestions of lamp oil products in both the NPDS 
data review and the multi-center study. These findings are supported by other studies in the 
literature.15–17
Results from the multi-center study found that the majority of ingestions occurred when the 
child was not alone. This finding suggests that mere reported presence of an adult in the 
general area did not eliminate the risk of exposure to a lamp oil product. Historically, 
inadequate parental or guardian supervision was a risk factor for exposure and probably still 
is. The Consumer Product Safety Commission (CPSC) under the Poison Prevention 
Packaging Act requires products like lamp oil to be sold in child-resistant packaging.18,19 
However, our survey found that most of the lamp oil and related products that were stored in 
their original containers did not reportedly have child-resistant closures. An increase in the 
risk of pediatric lamp oil ingestion has been attributed to the practice of transferring and 
storing products from their original containers to those without child-resistant packaging, 
such as lamps, candles, or torches.4,20 However the majority of our surveyed lamp oil 
ingestions reportedly drank oil from their original containers. Further studies evaluating 
increasing parental awareness of safer storage practices, proper use of child-safety 
mechanisms, and promoting effective product safety devices to industry may help reduce the 
number of pediatric exposures to these products.
In 2011, the CPSC was petitioned to prohibit lamp oil and related products to be sold in see-
through containers. Packaging as such was deemed “unnecessarily attractive” to children.21 
European countries have been attempting to reduce the morbidity and mortality from lamp 
oil exposures in their youth for years. In 1997 and 1999, the European Union restricted the 
sale of colored and perfumed oil in an attempt to decrease the risk of aspiration during 
unintentional pediatric exposures. A study by a group from the Netherlands compared 
pediatric exposures to lamp oil before and after implementation of the guidelines to assess 
its impact on the frequency and severity of symptoms from lamp oil exposure. The authors 
did not find a statistically significant difference between the frequency of severe symptoms 
before and after adoption of the European Union guidelines.9 Nevertheless, parents should 
be vigilant and aware of the danger these products pose to children regardless of how 
attractive or unattractive the lamp oil product or its packaging may appear to their children.
Most ingestions from the multi-center study were asymptomatic, suggesting that caregivers 
did not wait to see whether symptoms appeared but rather called the PC as soon as they 
discovered the exposure. Since hydrocarbon aspirations can manifest clinical and 
radiographic symptoms as late as 6 h after exposure, the earlier the call after exposure, the 
sooner proper medical evaluation can be initiated.
Limitations in our study include: the passive self-reporting nature of PC data, possibility of 
missing similar products not captured by the generic codes used in this study, possible 
inclusion of unconfirmed exposures in the characterization of NPDS exposures, the small 
sample size of the multi-PC part of our study relative to the number of exposures and 
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convenience sampling methodology (multi-center study part). Lack of a comparison group 
and recall bias are other potential substantial limitations since the survey was performed 
sometime after the exposure using available PC records. Additionally, the average ED and 
admission times reported were based on information supplied by survey respondents and not 
the medical records. Another limitation is that the population covered by the five 
participating PCs and even the data obtained from NPDS may not accurately reflect the 
demographics of the entire United States and thus, survey results may not be generalizable 
to all pediatric lamp oil ingestions.
Conclusion
Pediatric exposures to lamp oil products continue to occur. Lamp oil product exposures are 
most common among young children (around 2 years of age) while at home, not alone and 
as a result of the product being in a child-accessible location. There was increased frequency 
of these exposures during the summer months, particularly around the July 4th holidays. In 
our study, we found that the Midwest region had a higher than expected frequency of 
exposures for unknown reasons. Increasing parental awareness about potential health risks 
to children from these products and teaching safe storage and handling practices may help 
prevent both exposures and associated illness, however further studies evaluating the 
efficacy of these interventions are needed.
Abbreviations
AAPCC American Association of Poison Control Centers
CPSC Consumer Product Safety Commission
PCs Poison centers
PPPA Poison Prevention Packaging Act
NPDS National Poison Data System
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Fig. 1. 
Pediatric penetrance (PP) defined as the number of exposures per 10,000 estimated pediatric 
population of NPDS lamp oil calls (2000–2010) by region according to US Census Bureau, 
2000 (colour version of this figure can be found in the online version at 
www.informahealthcare.com/ctx).
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Table 1
American Association of Poison Control Centers medical outcome categories.13
No effect The patient did not develop any signs or symptoms as a result of the exposure
Minor effect The patient developed some signs or symptoms as a result of the exposure, but they were minimally 
bothersome and generally resolved rapidly with no residual disability or disfigurement. A minor effect is 
often limited to the skin or mucus membranes (e.g., self-limited gastrointestinal symptoms, drowsiness, skin 
irritation, first-degree dermal burn, sinus tachycardia without hypotension, and transient cough)
Moderate effect The patient exhibited signs or symptoms as a result of the exposure that were more pronounced, more 
prolonged, or more systemic in nature than minor symptoms. Usually, some form of treatment is indicated. 
Symptoms were not life-threatening, and the patient had no residual disability or disfigurement (e.g., corneal 
abrasion, acid-base disturbance, high fever, disorientation, hypotension that is rapidly responsive to 
treatment, and isolated brief seizures that respond readily to treatment)
Major effect The patient exhibited signs or symptoms as a result of the exposure that were life-threatening or resulted in 
significant residual disability or disfigurement (e.g., repeated seizures or status epilepticus, respiratory 
compromise requiring intubation, ventricular tachycardia with hypotension, cardiac or respiratory arrest, 
esophageal stricture, and disseminated intravascular coagulation)
Death The patient died as a result of the exposure or as a direct complication of the exposure. Only those deaths 
that were probably or undoubtedly related to the exposure are coded here
Not followed, judged as 
nontoxic exposure
No poison center follow-up calls were made to determine the outcome of the exposure because the substance 
implicated was nontoxic, the amount implicated was insignificant, or the route of exposure was unlikely to 
result in a clinical effect
Not followed, minimal clinical 
effects possible:
No poison center follow-up calls were made to determine the patient’ s outcome because the exposure was 
likely to result in only minimal toxicity of a trivial nature (the patient was expected to experience no more 
than a minor effect)
Unable to follow, judged as a 
potentially toxic exposure
The patient was lost to PC follow-up, refused follow-up, or was not followed, but the exposure was 
significant and may have resulted in a moderate, major, or fatal outcome
Unrelated effect The exposure was probably not responsible for the effect
Confirmed non-exposure This outcome option is coded to designate cases where there was reliable and objective evidence that an 
exposure initially believed to have occurred actually never occurred (e.g., all missing pills are later located)
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Table 2
Lamp oil exposure, management, outcome, and health effect data captured by NPDS from 2000 to 2010 (n = 
23,536).
Age (years) N (%)*
0–<1   3,838 (16.3)
1   9,588 (40.7)
2   7,368 (31.3)
3   1,768 (7.5)
4      607 (2.6)
5      367 (1.6)
Exposure site
 Own residence 21,510 (91.4)
 Other residence   1,694 (7.2)
 Public area      116 (0.5)
 Unknown        61 (0.3)
 Restaurant/food service        57 (0.2)
 Other        43 (0.2)
 School        31 (0.1)
 HCF        13 (0.1)
 Workplace        11 (<0.1)
Management site
 Managed on site (non HCF) 14,506 (61.6)
 Patient already in (en route to) HCF when PCC called   4,922 (20.9)
 Patient referred by PCC to HCF   3,914 (16.6)
 Other      120 (0.5)
 Unknown        74 (0.3)
Medical outcome
 No effect   7,608 (32.3)
 Not followed, minimal clinical effects possible   4,707 (20)
 Moderate effect   2,322 (9.9)
 Minor effect   6,155 (26.2)
 Not followed, judged as nontoxic exposure   1,269 (5.4)
 Unable to follow, judged as a potentially toxic exposure      923 (3.9)
 Unrelated effect      276 (1.2)
 Major effect      234 (1.0)
 Confirmed non-exposure        29 (0.1)
 Death          7 (<0.1)
 Unknown          6 (<0.1)
Top 10 clinical effects**
 None 12,843 (54.6)
 Cough/choke   8,027 (34.1)
 Vomiting   2,539 (10.8)
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Age (years) N (%)*
 X-ray findings   1,414 (6.0)
 Fever/hyperthermia   1,133 (4.8)
 Drowsiness/lethargy      820 (3.5)
 Dyspnea      709 (3.0)
 Hyperventilation/tachypnea      706 (3.0)
 Other      661 (2.8)
 Erythema/flushed      465 (2.0)
Top 10 therapies**
 Dilute/irrigate/wash 15,179 (64.5)
 None   5,620 (23.9)
 Other   2,044 (8.7)
 Food/snack   1,959 (8.3)
 Oxygen   1,295 (5.5)
 Antibiotics      627 (2.7)
 Bronchodilators      620 (2.6)
 Fluids, IV      603 (2.6)
 Fresh air      216 (0.9)
 Intubation      210 (0.9)
*
Percentages may not add up to 100% due to rounding.
**Clinical effects and therapies reported not mutually exclusive. Some calls reported multiple symptoms and/or received multiple therapies.
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Table 3
Aggregate demographic data on pediatric patients (≤5 years) with lamp oil product ingestions from five PCs (n 
= 39).
N (%)
Sex
 Male 22 (56.4)
 Female 17 (43.6)
Age
 1 year old 10 (25.6)
 2 years old 22 (56.4)
 3 years old   6 (15.4)
 4 years old   1 (2.6)
Race
 White 33 (84.6)
 African American   2 (5.1)
 Other   4 (10.3)
Caller ’s Relationship to Child
 Mother 24 (61.5)
 Father   8 (20.5)
 Grandmother   5 (12.8)
 Aunt   1 (2.6)
 Caretaker   1 (2.6)
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Table 4
Aggregate exposure data from pediatric patients (<5 years) with lamp oil product ingestions from five PCs (n 
= 39).
N (%)
Product name
 Tiki torch fuel 13 (33.3)
 Generic lamp oil 12 (30.8)
 Liquid candle   7 (17.9)
 Do not know   5 (12.8)
 Other 2 (5.1)
Characteristics of product
 Color
 Present 18 (46.2)
 Absent 17 (43.6)
 Not reported   4 (10.3)
Pleasant smell
 No 25 (64.1)
 Yes   9 (23.1)
 Did not know   5 (12.8)
Storage location
 Table/counter   6 (15.4)
 Torch/candle   5 (12.8)
 Cabinet   5 (12.8)
 Porch/deck/patio   5 (12.8)
 Shelf   5 (12.8)
 Garage 2 (5.1)
 Shed 2 (5.1)
 Other   9 (23.1)
Storage container
 Original container 23 (59.0)
Child-proof mechanism present
 Yes, No, Do not know 8 (34.8), 14 (60.9), 1 (4.3)
 Non-original container 16 (41.0)
Time of Ingestion
 Afternoon (noon–5:59 pm) 15 (38.5)
 Evening (6–11:59 pm) 15 (38.5)
 Morning (7–11:59 am)   9 (23.1)
Place of ingestion
 In the house 22 (56.4)
 Deck/patio/porch   9 (23.1)
 Backyard   6 (15.4)
 Public place 1 (2.6)
Clin Toxicol (Phila). Author manuscript; available in PMC 2015 August 17.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
SHEIKH et al. Page 16
N (%)
 Garage 1 (2.6)
Adult supervision
 Child was not alone 30 (76.9)
 Child was alone   9 (23.1)
Estimated amount ingested
 Less than a mouthful 24 (61.5)
 Mouthful   7 (17.9)
 More than a mouthful 3 (7.7)
 A taste 1 (2.6)
 Did not know   4 (10.3)
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Table 5
Aggregate sign, symptom, and management data from patients with lamp oil product ingestions from five PCs 
(n = 39).
N (%)
Number of symptoms
 None 18 (46.2)
 1   8 (20.5)
 2   4 (10.3)
 3   5 (12.8)
 4   1 (2.6)
 5   1 (2.6)
 6   2 (5.1)
Symptoms reported (not mutually exclusive)
 Cough 20 (51.3)
 Vomiting   8 (20.5)
 Difficulty breathing   7 (17.9)
 Choking   6 (15.4)
 Fever   4 (10.3)
 Lethargy/fatigue   2 (5.1)
 Skin changes   2 (5.1)
 Changes in stool   1 (2.6)
 Weakness/flaccid extremities   1 (2.6)
Agency/healthcare provider(s) notified of exposure*
 PC 33 (84.6)
 Police/9-1-1   4 (10.3)
 Pediatrician   2 (5.1)
 Fire department   1 (2.6)
 Hospital/emergency Department   1 (2.6)
Management sites
 Non-HCF 27 (69.2)
 Hospital ED   9 (23.1)
 Pediatrician’ s office   2 (5.1)
 Urgent care
  1 (2.6)**
Tests/treatment received
 Chest X-ray   7 (17.9)
 Blood test drawn   6 (15.4)
 Oxygen   5 (12.8)
 No medication   3 (7.7)
 Albuterol   3 (7.7)
 Antibiotic   3 (7.7)
 Intravenous line placed   3 (7.7)
 No procedures/tests   2 (5.1)
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N (%)
 Steroids   2 (5.1)
 Other respiratory support   2 (5.1)
 Antiemetic   1 (2.6)
 Ventilator   1 (2.6)
*
In three cases more than one center notified.
**
Patient initially presented to urgent care clinic then referred to ED.
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